CompletedNCT00158262
Effect of Propranolol on Preventing PTSD
It focuses on PTSD and currently lists study information in the United States.
PTSDDrugFrom 18 Years to 55 Years
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Boston, United StatesSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
Study information
Study start dateStarted: September 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 43
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00158262
- Official title
- Prophylaxis of Posttraumatic Stress Disorder With Post-Trauma Propranolol
Recruitment & locations
CompletedBoston
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Propranolol and Placebo.
Who was this study for?
Listed age limits: 18 years to 55 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me